MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells

被引:0
作者
Catharina Melzer
Juliane von der Ohe
Ralf Hass
机构
[1] Biochemistry and Tumor Biology Lab,
[2] Department of Obstetrics and Gynecology (OE 6410),undefined
[3] Hannover Medical School,undefined
来源
Cell Communication and Signaling | / 16卷
关键词
Mesenchymal stem cells; Breast and ovarian cancer; Tumor microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor microenvironment enables important cellular interactions between cancer cells and recruited adjacent populations including mesenchymal stroma/stem cells (MSC). In vivo cellular interactions of primary human MSC in co-culture with human SK-OV-3 ovarian cancer cells revealed an increased tumor growth as compared to mono-cultures of the ovarian cancer cells. Moreover, the presence of MSC stimulated formation of liver metastases. Further interactions of MSC with the ovarian cancer cells resulted in the formation of hybrid cells by cell fusion. Isolation and single cell cloning of these hybrid cells revealed two differentially fused ovarian cancer cell populations termed SK-hyb1 and SK-hyb2. RNA microarray analysis demonstrated expression profiles from both parental partners whereby SK-hyb1 were attributed with more SK-OV-3 like properties and SK-hyb2 cells displayed more similarities to MSC. Both ovarian cancer hybrid populations exhibited reduced proliferative capacity compared to the parental SK-OV-3 cells. Moreover, the fused populations failed to develop tumors in NODscid mice. Together, these data suggested certain stimulatory effects on ovarian tumor growth in the presence of MSC. Conversely, fusion of MSC with SK-OV-3 cells contributed to the generation of new cancer hybrid populations displaying a significantly reduced tumorigenicity.
引用
收藏
相关论文
共 216 条
[1]  
Dubeau L(2008)The cell of origin of ovarian epithelial tumours Lancet Oncol 9 1191-1197
[2]  
Hafner N(2013)p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer J Cancer Res Clin Oncol 139 1207-1210
[3]  
Nicolaus K(2008)Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis Am J Obstet Gynecol 198 351-356
[4]  
Weiss S(2010)The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 433-443
[5]  
Frey M(2012)Therapeutic strategies in epithelial ovarian cancer J Exp Clin Cancer Res 31 14-650
[6]  
Diebolder H(2011)Interaction of tumor cells with the microenvironment Cell Commun Signal 9 18-108
[7]  
Rengsberger M(1991)Mesenchymal stem cells J Orthop Res 9 641-704
[8]  
Durst M(1971)Osteogenic precursor cells of bone marrow in radiation chimeras Transplantation 12 99-12
[9]  
Runnebaum IB(2014)"mesenchymal" stem cells Annu Rev Cell Dev Biol 30 677-147
[10]  
Kurman RJ(2011)Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC Cell Commun Signal 9 12-2587